MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41409-024-02414-z

Медицинская библиотека · Bone marrow transplantation · 2024

Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.

Salas María Queralt, Cascos Enric, López-García Alberto, Pérez-López Estefanía, Baile-González Mónica, López-Corral Lucía, Pascual Cascón María Jesús, Luque Marta, Esquirol Albert, Heras Fernando Inmaculada, Oiartzabal Ormtegi Itziar, Sáez Marín Adolfo Jesús, Peña-Muñóz Felipe, Fernández-Luis Sara, Domínguez-García Juan José, Villar Fernández Sara, Fernández de Sanmamed Girón Miguel, González Pinedo Leslie, González-Rodríguez Ana Pilar, Torrado Tamara, García Lucía, Filaferro Silvia, Cedillo Ángel, Basalobre Pascual, Ortí Guillermo, Jurado Chacón Manuel

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

This multicenter study investigates the incidence and predictors of cardiac events (CE) following allo-HCT with PTCY in 453 AML patients. CE occurred in 57 (12.3%) patients within a median of 52 days (IQR: 13-289), with day 100 and 5-year cumulative incidences of 7.7% and 13.5%. Early (first 100 days) and late CE occurred at rates of 7.7% and 4.8%. The most prevalent CE were heart failure (n = 18, 31.6%), pericardial complications (n = 16, 28.1%), and arrhythmia (n = 14, 24.6%). The proportions of patients older than 55 years (64.9% vs. 46.1%, P = 0.010), with hypertension (36.8% vs. 18.4%, P = 0.001) and dyslipidemia (28.1% vs. 11.1%, P = 0.001) were higher in patients with CE. Patients undergoing haplo-HCT trend to have more CE (68.4% vs. 56.8%, P = 0.083). The multivariate regression analysis revealed that only hypertension (HR 1.88, P = 0.036) and dyslipidemia (HR 2.20, P = 0.018) were predictors for CE, with no differences according to donor type (haplo-HCT vs. others: HR 1.33, P = 0.323). Among the 57 patients with CE, the mortality rate was 12.2%. Notably, the diagnosis of CE negatively impacted NRM (HR 2.57, P = 0.011) and OS (HR 1.80, P = 0.009), underscoring necessity of aggressively treating cardiovascular risk factors, and implementing post-transplant cardiac monitoring protocols to prevent these complications.

Для цитирования: Salas María Queralt, Cascos Enric, López-García Alberto, Pérez-López Estefanía, Baile-González Mónica, López-Corral Lucía, Pascual Cascón María Jesús, Luque Marta, Esquirol Albert, Heras Fernando Inmaculada, Oiartzabal Ormtegi Itziar, Sáez Marín Adolfo Jesús, Peña-Muñóz Felipe, Fernández-Luis Sara, Domínguez-García Juan José, Villar Fernández Sara, Fernández de Sanmamed Girón Miguel, González Pinedo Leslie, González-Rodríguez Ana Pilar, Torrado Tamara, García Lucía, Filaferro Silvia, Cedillo Ángel, Basalobre Pascual, Ortí Guillermo, Jurado Chacón Manuel. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.. Bone marrow transplantation. 2024. DOI: 10.1038/s41409-024-02414-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.